A new Florida State University study is changing how scientists look at diabetes research and the drugs used to treat the disease.
In a recent issue of the Proceedings of the National Academy of Sciences, Associate Professor of Chemistry Brian Miller and post-doctoral researcher Carl Whittington report that a key enzyme involved in the body’s response to glucose can essentially be corrupted by a new mechanism that scientists have not seen before. This discovery shifts the current understanding of how this enzyme participates in certain diseases, including hyperinsulinemia and diabetes.
For more visit http://fla.st/1Ocb18P.